Survivors for Solutions

Mission

Survivors for Solutions seeks to preserve and protect the medical innovations that give people hope. It strives to value, celebrate, and put a human face to the impact of scientific breakthroughs and the policy that supports them. We endeavor to hold lawmakers accountable, ensure facts are presented accurately, and that the voices of survivors are heard. We will stand up for those that are impacted by healthcare policy changes and ensure that innovation and the hope it provides can continue to thrive.

Why?

Millions of patients are living with a life-threatening, chronic, or rare disease. They are either on current treatments or waiting for new care options to help them manage their evolving symptoms. We are here to safeguard their fundamental right to hope.

Over decades, the innovations of a thriving biopharmaceutical industry provided people with treatments and therapies, saved and prolonged countless lives, and brought many hope despite life-altering health conditions. However, many policymakers in the current political environment find it easier to attack than understand. They will conveniently ignore survivors and how they directly benefit from pharmaceutical researchers and manufacturers. Doing so without examining what really drives the ever-increasing cost of healthcare, exposing bad actors within the healthcare system, or explaining how much is wasted without it ever reaching a patient’s bedside.

In other words, these politicians are choosing poll-tested talking points over clinically proven solutions that actually make a difference. This results in shortsighted policies and prioritizing political “wins” over patient success. Without policies that support current and future access to cutting-edge treatments and R&D efforts, untold numbers of patients are disregarded and left behind.

Action is needed.

Survivors For Solutions is a nonprofit patient advocacy organization created by John Czwartacki to stand up for those who are in need of solutions for their health challenges but are too often without a voice in Washington. We aim to correct the record, as well as amplify how impactful medical innovation is for patients across this country. As a 30-year survivor of Multiple Sclerosis (MS), Czwartacki understands the importance of medical innovation and has lived this experience throughout his adult life. It’s why he’s calling out policies that hamper our country’s ability to create new drugs and supporting measures that invest in future discoveries.